These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 34315786)

  • 1. Innovating Clinical Trials for Amyotrophic Lateral Sclerosis: Challenging the Established Order.
    van Eijk RPA; Nikolakopoulos S; Roes KCB; Kendall L; Han SS; Lavrov A; Epstein N; Kliest T; de Jongh AD; Westeneng HJ; Al-Chalabi A; Van Damme P; Hardiman O; Shaw PJ; McDermott CJ; Eijkemans MJC; van den Berg LH
    Neurology; 2021 Sep; 97(11):528-536. PubMed ID: 34315786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?
    Zach N; Ennist DL; Taylor AA; Alon H; Sherman A; Kueffner R; Walker J; Sinani E; Katsovskiy I; Cudkowicz M; Leitner ML
    Neurotherapeutics; 2015 Apr; 12(2):417-23. PubMed ID: 25613183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical design considerations for time-to-event endpoints in amyotrophic lateral sclerosis clinical trials.
    van Eijk RPA; Nikolakopoulos S; Roes KCB; Middelkoop BM; Ferguson TA; Shaw PJ; Leigh PN; Al-Chalabi A; Eijkemans MJC; van den Berg LH
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1331-1337. PubMed ID: 31292200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design.
    Fournier CN
    Neurotherapeutics; 2022 Jul; 19(4):1180-1192. PubMed ID: 35819713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PRO-ACT database: design, initial analyses, and predictive features.
    Atassi N; Berry J; Shui A; Zach N; Sherman A; Sinani E; Walker J; Katsovskiy I; Schoenfeld D; Cudkowicz M; Leitner M
    Neurology; 2014 Nov; 83(19):1719-25. PubMed ID: 25298304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism.
    Mehta P; Raymond J; Han MK; Larson T; Berry JD; Paganoni S; Mitsumoto H; Bedlack RS; Horton DK
    J Med Internet Res; 2021 Dec; 23(12):e28021. PubMed ID: 34878988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using an onset-anchored Bayesian hierarchical model to improve predictions for amyotrophic lateral sclerosis disease progression.
    Karanevich AG; Statland JM; Gajewski BJ; He J
    BMC Med Res Methodol; 2018 Feb; 18(1):19. PubMed ID: 29409450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All?
    Nicholson KA; Cudkowicz ME; Berry JD
    Neurotherapeutics; 2015 Apr; 12(2):376-83. PubMed ID: 25700798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A placebo arm is not always necessary in clinical trials of amyotrophic lateral sclerosis.
    Gordon PH
    Muscle Nerve; 2009 Jun; 39(6):858-60. PubMed ID: 19382169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current trends in the clinical trial landscape for amyotrophic lateral sclerosis.
    van Eijk RPA; Kliest T; van den Berg LH
    Curr Opin Neurol; 2020 Oct; 33(5):655-661. PubMed ID: 32796282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial.
    Aggarwal SP; Zinman L; Simpson E; McKinley J; Jackson KE; Pinto H; Kaufman P; Conwit RA; Schoenfeld D; Shefner J; Cudkowicz M;
    Lancet Neurol; 2010 May; 9(5):481-8. PubMed ID: 20363190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyotrophic lateral sclerosis: lessons in trial design from recent trials.
    Borasio GD
    J Neurol Sci; 1997 Oct; 152 Suppl 1():S23-8. PubMed ID: 9419050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease.
    Diana A; Pillai R; Bongioanni P; O'Keeffe AG; Miller RG; Moore DH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006049. PubMed ID: 28067943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model-Based and Model-Free Techniques for Amyotrophic Lateral Sclerosis Diagnostic Prediction and Patient Clustering.
    Tang M; Gao C; Goutman SA; Kalinin A; Mukherjee B; Guan Y; Dinov ID
    Neuroinformatics; 2019 Jul; 17(3):407-421. PubMed ID: 30460455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach.
    Thakore NJ; Lapin BR; Kinzy TG; Pioro EP
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):483-494. PubMed ID: 30001159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials in amyotrophic lateral sclerosis.
    McDermott CJ
    Curr Opin Neurol; 2019 Oct; 32(5):758-763. PubMed ID: 31335338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creatine for amyotrophic lateral sclerosis/motor neuron disease.
    Pastula DM; Moore DH; Bedlack RS
    Cochrane Database Syst Rev; 2010 Jun; (6):CD005225. PubMed ID: 20556761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urate levels predict survival in amyotrophic lateral sclerosis: Analysis of the expanded Pooled Resource Open-Access ALS clinical trials database.
    Paganoni S; Nicholson K; Chan J; Shui A; Schoenfeld D; Sherman A; Berry J; Cudkowicz M; Atassi N;
    Muscle Nerve; 2018 Mar; 57(3):430-434. PubMed ID: 28857199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Dynamic Bayesian Network model for the simulation of Amyotrophic Lateral Sclerosis progression.
    Zandonà A; Vasta R; Chiò A; Di Camillo B
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):118. PubMed ID: 30999865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.